CA2611645A1 - New stem cell things (innovations) - Google Patents

New stem cell things (innovations) Download PDF

Info

Publication number
CA2611645A1
CA2611645A1 CA002611645A CA2611645A CA2611645A1 CA 2611645 A1 CA2611645 A1 CA 2611645A1 CA 002611645 A CA002611645 A CA 002611645A CA 2611645 A CA2611645 A CA 2611645A CA 2611645 A1 CA2611645 A1 CA 2611645A1
Authority
CA
Canada
Prior art keywords
stem cells
cells
skin
neutrophin
see
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002611645A
Other languages
French (fr)
Inventor
Gerard Voon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002611645A priority Critical patent/CA2611645A1/en
Publication of CA2611645A1 publication Critical patent/CA2611645A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073Stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

We want to use the product Dermatix or some equivalent product to 1) try to proliferate stem cells and 2) use it for scarred tissue inside the body a procedure done before grafting or adding or scaffolding stem cells (eg. into a spinal chord injury patient) so the stem cells aren't blocked from taking to injured wound.

Taken from Dermatix website:
The Innovation Dermatix.TM. Gel is a patented proprietary formula containing bio-inert and biocompatible silicone compounds, namely polysiloxane, silicon dioxide and nonvolatile silicone components. It uses basic long-chain polymers as topical silicone-gel sheeting. The result is a waterproof, gas-permeable membrane that acts like an extra layer of skin. It helps to soften and flatten the scar and to reduce pain, itching and scar-associated discoloration, while maintaining the moisture balance and elasticity of the adjacent skin.
We are looking at running electrode through stem cell colonies to deliver electrical impulses to the stem cells in the hope of continuing the stem cells proliferation.

We also plan to use Netrin-1 protein 1) harness and study its effects to facilitate the stem cells to repair itself to and use to cause stem cells to proliferate 2) and cause the stem cells to convert into axons for spinal chord and brain injuries 3) we could also use it in conjunction stem cell injections.

Other Topical Ointments include:

Retin-A (tretinoin) perhaps in combination with hydroquinone and cortisone cream and as well alpha hydroxy acids and vitamin C serums and possibly steroids such as triamcinolone.
We are using Helix Aspera Muller Glycoconjugates snail/slug slime to enhance proliferation of stem cells. It is comprised complex sugar molecules bound to proteins, peptides, enzymes, coenzymes, oligoelements that play a role in messengers's communication between cells moderators of inflammatory reaction when skin if damaged, and regulators of fiberoblast proliferation and functions of the skin matrix and new connective tissues such as collagen and elastin fibers and water holding molecules (glycosaminoglycans and proteoglycans.

The Below is Taken BioSkincare Website:
FACTORS THAT HELP TO RECOVER THE NORMAL PHYSIOLOGY OF THE SKIN.
~ Low molecular weight proteins that activate Fibroblast Growth Factor activity. Fibroblast proliferation is key for they are the stem cells in the basal membrane of the skin that give rise to new connective tissues: collagen and elastin fibers plus the glycosaminoglycans and proteoglycans that act as the glue that bind cells together and as fillers with a large capacity to withhold many times their weight in water and give skin strenght, elasticity and the capcity to withstand overstretching without breaking of skin fibers.

~ High molecular weight proteins that work as Oxygen carriers (copper-haemocyanin) ~ Copper peptides that induce the degradation of "extra-large" collagen aggregates found in scar tissues such as those in stretch marks, and promotes the synthesis of smaller more regular collagen as is normal skin ~ Enzymes, both with Collagenase and Gelatinase activities that degrade damaged proteins and scar tissues ~ Hyaluronic Acid, provides deep tissue hydration ~ Glycoproteins / mucopolysaccharides that act as signaling molecules and enhance communication among and within cells, thus coordinating an orchestrated process that recognizes damaged and scar tissues, and activates the enzymes that "digest" or further degrade them into their amino-acid and other components, and uses those same components for the reconstruction of the extracellular matrix ~ Trace elements (Copper, Zinc, Iron, Calcium), some acting as coenzymes, necessary for Cellular Renewal, ~ Low molecular weight antioxidant compounds with Antioxidant & Anti-inflammatory effects.

We also plan to use it in conjunction with (prior to) injecting stem cells into scarred injury (eg.
scarred tissue) anywhere where there is scarred tissue.

After removing the scarring, and adding stem cells to the injured area of the spinal chord, we use netrein-1 then we apply electrodes to prime the stem cells to grow into stem cells.

Additionally we could use detectors for faint muscle signals (initially with robotic help the limb's movement) then as the signal gets stronger, by retrains the brain signalling (neuron sounds or other form or mental activity detector) we could add neuron muscle patches that strengthens the muscle and eventually turn down the strength of the nerve patch signal and teach the patient to concentrate to increase the brains and nerve signals that operate the limb movement manually.

Furthermore, we will treat the stem cells with retinoic acid and vitamin A and (different concentrations of) frizzled WNT (G proteins), (sonic) hedgehog (agonists - Hh protein, Hh-Ag1.1, Hh-Ag1.2, vehicle (DMSO) pathways SAG, purmorphamine (smoothened) and nerve growth factor (NGF), brain derived neutrophic factor (BDNF), neutrophin-1 (NT-1), neutrophin-2 (NT-3), neutrophin-4 (NT-4) and possibly other growth factors. We also are looking at transcription factors Pax7, MNR2Nkx2.2.
We culture stem cells in dibutyrl camp (dbcAMP), then we add rolipram, GDNF, and with motor neurons and neurons and different types of interneurons (as converted to stem cells by differing concentrations of sonic hedgehog). Dr. Kerr.

Breaks that need new bridging... the sciatic nerve extends from the spine down the back of the hind leg, and extending into the peripheral nervous system and all the way down to the gastronemius muscle in the lower leg and formed functional connections called synapses, with the muscles. Dr, Kerr.

We are also developing ways to observe cells innards via micro (real time x-ray, Cat Scan, fMRI, MRI or micro video probe - in REAL TIME 1) Lower Power to see through the cell membrane to see the cytoplasm and organelles eg mitochondria, 2) Medium Power to see through the mitochondria and 3) High Power to see through the nuclear membrane). The idea in this case is to sort the types of neural cells at a stem cells early stage. We are initially looking setting up an assembly line of colonies that the micro video camera observes to determine the different cells we look for types by shapes, size (of cells and organelles) positioning/orientation and placement (where suspended), conductivity (effects of electro pulse on different types of cells) of innards to their DNA orientation, make up of cytoplasm and percentage relative size of eg. cytosol to mitochondria (numbers), protrusions on the cellular membrane (receptors) - eg. dendrites are shown to have axons (but are they there in early stage of development...).

Then there is the question of do we need to separate the neural cells if the cells are used for spinal cord injury.

Description

November 17t" 2007 Gerard Voon Note: not to be publicly published until International Patent Application has occurred Desc(ption We want to use the product Dermatix or some equivalent product to 1) try to proliferate stem cells and 2) use it for scarred tissue inside the body a procedure done before grafting or adding or scaffolding stem cells (eg. into a spinal chord injury patient) so the stem cells aren't blocked from taking to injured wound.

Taken from Dermatix website:
The Innovation DermatixTM Gel is a patented proprietary formula containing bio-inert and biocompatible silicone compounds, namely polysiloxane, silicon dioxide and nonvolatile silicone components. It uses basic long-chain polymers as topical silicone-gel sheeting. The resu(t is a waterproof, gas-permeable membrane that acts like an extra layer of skin. It helps to soften and flatten the scar and to reduce pain, itching and scar-associated discoloration, while maintaining the moisture balance and elasticity of the adjacent skin.

Other Topical Ointments include:

Retin-A (tretinoin) perhaps in combination with hydroquinone and cortisone cream and as well alpha hydroxy acids and vitamin C serums and possibly steroids such as triamcinolone.
We are looking at running electrode through stem cell colonies to deliver electrical impulses to the stem cells in the hope of continuing the stem celis proliferation.

We also plan to use Netrin-1 protein 1) harness and study its effects to facilitate the stem cells to repair itself to and use to cause stem cells to proliferate 2) and cause the stem cells to convert into axons for spinal chord and brain injuries 3) we could also use it in conjunction stem cell injections.

We are using Helix Aspera Muller Glycoconjugates brown garden snail/slug slime to enhance proliferation of stem cells. It is comprised complex sugar molecules bound to proteins, peptides, enzymes, coenzymes, oligoelements that play a role in messengers's communication between cells moderators of inflammatory reaction when skin if damaged, and regulators of fiberoblast proliferation and functions (collagen synthesis) fibronectin deposit on the extraceillular matrix and hyaluronic acid and new connective tissues such as collagen and elastin fibers and water holding molecules (glycosaminoglycans and proteoglycans which all contribute to wound healing.

The Below is Taken BioSkincare Website:
FACTORS THAT HELP TO RECOVER THE NORMAL PHYSIOLOGY OF THE SKIN.

:1 Low molecular weight proteins that activate Fibroblast Growth Factor activity. Fibroblast proliferation is key for they are the stem cells in the basal membrane of the skin that give rise to new connective tissues: coliagen and elastin fibers plus the glycosaminoglycans and proteoglycans that act as the glue that bind cells together and as fillers with a large capacity to withhold many times their weight in water and give skin strenght, elasticity and the capcity to withstand overstretching without breaking of skin fibers.

--1 High molecular weight proteins that work as Oxygen carriers (copper-haemocyanin) 1 Copper peptides that induce the degradation of "extra-large" collagen aggregates found in scar tissues such as those in stretch marks, and promotes the synthesis of smaller more regular collagen as is normal skin -7 Enzymes, both with Coliagenase and Gelatinase activities that degrade damaged proteins and scar tissues A Hyaluronic Acid, provides deep tissue hydration -1 Glycoproteins / mucopolysaccharides that act as signaling molecules and enhance communication among and within cells, thus coordinating an orchestrated process that recognizes damaged and scar tissues, and activates the enzymes that "digest" or further degrade them into their amino-acid and other components, and uses those same components for the reconstruction of the extracellular matrix :1 Trace elements (Copper, Zinc, Iron, Calcium), some acting as coenzymes, necessary for Cellular Renewal, :1 Low molecular weight antioxidant compounds with Antioxidant & Anti-Inflammatory effects.

We also plan to use it in conjunction with (prior to) injecting stem cells into scarred injury (eg. scarred tissue) anywhere where there is scarred tissue.

After removing the scarring (and either swabbing or flushing the scar removing substance off), we add stem cells to the injured area of the spinal chord, we use netrein-1 then we apply electrodes to prime the stem cells to grow into stem cells.
Additionally we could use detectors for faint muscle signals (initially with robotic help the limb's movement) then as the signal gets stronger, by retrains the brain signalling (neuron sounds or other form or mental activity detector) we could add neuron muscle patches that strengthens the muscle and eventually tum down the strength of the nerve patch signal and teach the patient to concentrate to increase the brains and nerve signals that operate the limb movement manually.

Furthermore, we will treat the stem cells with retinoic acid and vitamin A and (different concentrations of) frizzled WNT (G proteins), (sonic) hedgehog (agonists - Hh protein, Hh-Ag1.1, Hh-Ag1.2, vehicle (DMSO) pathways SAG, purmorphamine (smoothened) and nerve growth factor (NGF), brain derived neutrophic factor (BDNF), neutrophin-1 (NT-1), neutrophin-2 (NT-3), neutrophin-4 (NT-4) and possibly other growth factors. We also are looking at transcription factors Pax7, MNR2Nkx2.2.
We culture stem cells in dibutyrl camp (dbcAMP), then we add rolipram, GDNF, and with motor neurons and neurons and different types of interneurons (as converted to stem cells by differing concentrations of sonic hedgehog). Dr. Kerr.

Breaks that need new bridging... the sciatic nerve extends from the spine down the back of the hind leg, and extending into the peripheral nervous system and all the way down to the gastronemius muscle in the lower leg and formed functional connections called synapses, with the muscles. Dr, Kerr.

We are also developing ways to observe cells innards via micro (real time x-ray, Cat Scan, fMRI, MRI or micro video probe - in REAL TIME 1) Lower Power to see through the cell membrane to see the cytoplasm and organelles eg mitochondria, 2) Medium Power to see through the mitochondria and 3) High Power to see through the nuclear membrane). The idea in this case is to sort the types of neural cells at a stem cells early stage. We are initially looking setting up an assembly line of colonies that the micro video camera observes to determine the different cells we look for types by shapes, size (of cells and organelles) positioning/orientation and placement (where suspended), conductivity (effects of electro pulse on different types of cells) of innards to their DNA orientation, make up of cytoplasm and percentage relative size of eg. cytosol to mitochondria (numbers), protrusions on the cellular membrane (receptors) - eg. dendrites are shown to have axons (but are they there in early stage of development...).

Then there is the question of do we need to separate the neural cells if the cells are used for spinal cord injury.

Claims (2)

1 (NT-1), neutrophin-2 (NT-3), neutrophin-4 (NT-4) and possibly other growth factors.
Furthermore, we will treat the stem cells with retinoic acid and vitamin A and (different concentrations of) frizzled WNT (G proteins), (sonic) hedgehog (agonists - Hh protein, Hh-Ag1.1, Hh-Ag1.2, vehicle (DMSO) pathways SAG, purmorphamine (smoothened) and nerve growth factor (NGF), brain derived neutrophic factor (BDNF), neutrophin-1 (NT-1), neutrophin-2 (NT-3), neutrophin-4 (NT-4) and possibly other growth factors. We also are looking at transcription factors Pax7, MNR2Nkx2.2.
We culture stem cells in dibutyrl camp (dbcAMP), then we add rolipram, GDNF, and with motor neurons and neurons and different types of interneurons (as converted to stem cells by differing concentrations of sonic hedgehog). Dr. Kerr.

Breaks that need new bridging... the sciatic nerve extends from the spine down the back of the hind leg, and extending into the peripheral nervous system and all the way down to the gastronemius muscle in the lower leg and formed functional connections called synapses, with the muscles. Dr, Kerr.

We are also developing ways to observe cells innards via micro (real time x-ray, Cat Scan, fMRI, MRI or micro video probe - in REAL TIME 1) Lower Power to see through the cell membrane to see the cytoplasm and organelles eg mitochondria,
2) Medium Power to see through the mitochondria and 3) High Power to see through the nuclear membrane). The idea in this case is to sort the types of neural cells at a stem cells early stage. We are initially looking setting up an assembly line of colonies that the micro video camera observes to determine the different cells we look for types by shapes, size (of cells and organelles) positioning/orientation and placement (where suspended), conductivity (effects of electro pulse on different types of cells) of innards to their DNA orientation, make up of cytoplasm and percentage relative size of eg. cytosol to mitochondria (numbers), protrusions on the cellular membrane (receptors) - eg. dendrites are shown to have axons (but are they there in early stage of development... ).

Then there is the question of do we need to separate the neural cells if the cells are used for spinal cord injury.
CA002611645A 2007-11-20 2007-11-20 New stem cell things (innovations) Abandoned CA2611645A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002611645A CA2611645A1 (en) 2007-11-20 2007-11-20 New stem cell things (innovations)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002611645A CA2611645A1 (en) 2007-11-20 2007-11-20 New stem cell things (innovations)

Publications (1)

Publication Number Publication Date
CA2611645A1 true CA2611645A1 (en) 2009-05-20

Family

ID=40652829

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002611645A Abandoned CA2611645A1 (en) 2007-11-20 2007-11-20 New stem cell things (innovations)

Country Status (1)

Country Link
CA (1) CA2611645A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011092350A1 (en) * 2010-01-28 2011-08-04 Industrial Farmacéutica Cantabria, S.A. Product for the preparation of dermatological, cosmetic or cosmeceutical compositions intended for skin treatment

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011092350A1 (en) * 2010-01-28 2011-08-04 Industrial Farmacéutica Cantabria, S.A. Product for the preparation of dermatological, cosmetic or cosmeceutical compositions intended for skin treatment
ES2398809A1 (en) * 2010-01-28 2013-03-21 Industrial Farmacéutica Cantabria, S.A. Product for the preparation of dermatological, cosmetic or cosmeceutical compositions intended for skin treatment
US10391050B2 (en) 2010-01-28 2019-08-27 Industrial Farmacéutica Cantabria, S.A. Dermatological, cosmetic or cosmeceutical compositions intended for skin treatment

Similar Documents

Publication Publication Date Title
Dong et al. Conductive hydrogel for a photothermal-responsive stretchable artificial nerve and coalescing with a damaged peripheral nerve
Courtine et al. Spinal cord repair: advances in biology and technology
Li et al. Cyborg organoids: implantation of nanoelectronics via organogenesis for tissue-wide electrophysiology
Ferrigno et al. Bioactive polymeric materials and electrical stimulation strategies for musculoskeletal tissue repair and regeneration
Muskovich et al. Biomaterials‐based electronics: polymers and interfaces for biology and medicine
Petty et al. Conducting polymers for tissue regeneration in vivo
US20040236320A1 (en) Method and apparatus for the control and monitoring of shape change in tissue
WO2015145495A1 (en) Biological-tissue attachment kit and biological-tissue attachment patch
Pesqueira et al. Magnetotherapy: The quest for tendon regeneration
Wu et al. Conductive hydroxyethyl cellulose/soy protein isolate/polyaniline conduits for enhancing peripheral nerve regeneration via electrical stimulation
CN103110936A (en) Biological preparation for promoting quick growth and repair of skin tissue
Liu et al. An electroconductive hydrogel scaffold with injectability and biodegradability to manipulate neural stem cells for enhancing spinal cord injury repair
Maeng et al. Electroceuticals for peripheral nerve regeneration
Carraro et al. Slow-like electrostimulation switches on slow myosin in denervated fast muscle
CA2611645A1 (en) New stem cell things (innovations)
Meng et al. Peripferal nerve regeneration in response to synthesized nanofiber scaffold hydrogel
Ou et al. The effects of electrical stimulation on neurite outgrowth of goldfish retinal explants
CA2613026A1 (en) Added new stem cells processes/methods/techniques
Wei et al. In situ multimodal transparent electrophysiological hydrogel for in vivo miniature two-photon neuroimaging and electrocorticogram analysis
CN1326576C (en) Biological restoration material, prepn. method and applicatino thereof
CA2619029A1 (en) New cell technologies
Reisi et al. Determination of the extracellular basal levels of glutamate and GABA at dentate gyrus of streptozotocin-induced diabetic rats
Mao et al. Analysis of influencing factors of repair effect after peripheral nerve injury
Liu et al. Research advances in the regulation of the putative ovarian germline stem cell niche on female germline stem cells
Shen et al. Immunological mechanisms of scarring and their psychological impact on patients

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20121120